Emergent BioSolutions Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Emergent BioSolutions Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Emergent BioSolutions Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$204M, a 30.5% increase year-over-year.
  • Emergent BioSolutions Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$450M, a 16.9% increase year-over-year.
  • Emergent BioSolutions Inc. annual Operating Income (Loss) for 2023 was -$726M, a 327% decline from 2022.
  • Emergent BioSolutions Inc. annual Operating Income (Loss) for 2022 was -$170M, a 150% decline from 2021.
  • Emergent BioSolutions Inc. annual Operating Income (Loss) for 2021 was $341M, a 22.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$450M -$204M +$89.4M +30.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$539M $39.8M +$187M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$726M -$43.8M +$11.5M +20.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 -$738M -$242M -$197M -434% Jul 1, 2023 Sep 30, 2023 10-Q 2023-12-11
Q2 2023 -$541M -$293M -$217M -284% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$325M -$148M -$155M -2239% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$170M -$55.3M -$342M -119% Oct 1, 2022 Dec 31, 2022 10-K/A 2023-12-11
Q3 2022 $172M -$45.3M -$600K -1.34% Jul 1, 2022 Sep 30, 2022 10-Q 2023-12-11
Q2 2022 $173M -$76.3M -$83.4M -1175% Apr 1, 2022 Jun 30, 2022 10-Q 2023-12-11
Q1 2022 $256M $6.9M -$85.3M -92.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-12-11
Q4 2021 $341M $287M +$28.7M +11.1% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-12-11
Q3 2021 $313M -$44.7M -$106M -173% Jul 1, 2021 Sep 30, 2021 10-K/A 2023-12-11
Q2 2021 $419M $7.1M -$119M -94.4% Apr 1, 2021 Jun 30, 2021 10-K/A 2023-12-11
Q1 2021 $538M $92.2M +$104M Jan 1, 2021 Mar 31, 2021 10-K/A 2023-12-11
Q4 2020 $434M $258M +$180M +232% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-19
Q3 2020 $254M $61.3M -$9.4M -13.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $263M $126M +$133M Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $130M -$11.6M +$15.8M +57.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $114M $77.8M +$66.6M +595% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-19
Q3 2019 $47.5M $70.7M +$49.4M +232% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-19
Q2 2019 -$1.9M -$7M -$73.8M -110% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-19
Q1 2019 $71.9M -$27.4M -$17.9M -188% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-19
Q4 2018 $89.8M $11.2M -$41.9M -78.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $132M $21.3M -$26.5M -55.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $158M $66.8M +$58.3M +683% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $99.9M -$9.5M -$24.4M -164% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $124M $53.1M +$2.19M +4.29% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $122M $47.8M +$12.3M +34.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $110M $8.53M +$10.6M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $99.3M $14.9M -$6.25M -29.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $106M $50.9M +$1.02M +2.03% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-22
Q3 2016 $104M $35.5M -$27.7M -43.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $132M -$2.04M -$23.5M -110% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $156M $21.2M +$49.5M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $106M $49.9M +$5.27M +11.8% Oct 1, 2015 Dec 31, 2015 10-K 2016-02-29
Q3 2015 $101M $63.2M +$32.1M +104% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $68.8M $21.5M +$13.6M +173% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $55.2M -$28.3M -$2.85M -11.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $58.1M $44.6M +$21.3M +91.6% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 $36.7M $31M +$12.9M +71% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 $23.8M $7.86M -$6.85M -46.6% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 $30.7M -$25.5M -$12.1M -90.7% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 $42.8M $23.3M -$742K -3.09% Oct 1, 2013 Dec 31, 2013 10-K/A 2015-03-09
Q3 2013 $43.5M $18.1M +$8.33M +84.9% Jul 1, 2013 Sep 30, 2013 10-K/A 2015-03-09
Q2 2013 $35.2M $14.7M +$6.06M +70% Apr 1, 2013 Jun 30, 2013 10-K/A 2015-03-09
Q1 2013 $29.2M -$13.4M -$812K -6.48% Jan 1, 2013 Mar 31, 2013 10-K/A 2015-03-09
Q4 2012 $30M $24M -$22M -47.7% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-10
Q3 2012 $51.9M $9.82M +$8.41M +597% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-10
Q2 2012 $43.5M $8.65M -$11.6M -57.2% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-10
Q1 2012 $55.1M -$12.5M +$23M +64.7% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-10
Q4 2011 $32.1M $46M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-08
Q3 2011 $1.41M -$19.2M -93.2% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-08
Q2 2011 $20.2M +$5.4M +36.4% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-08
Q1 2011 -$35.5M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-08
Q3 2010 $20.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $14.8M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.